Sally A. Mullany

1.3k total citations
22 papers, 899 citations indexed

About

Sally A. Mullany is a scholar working on Molecular Biology, Reproductive Medicine and Surgery. According to data from OpenAlex, Sally A. Mullany has authored 22 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Reproductive Medicine and 6 papers in Surgery. Recurrent topics in Sally A. Mullany's work include Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Cancer-related molecular mechanisms research (5 papers). Sally A. Mullany is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Cancer-related molecular mechanisms research (5 papers). Sally A. Mullany collaborates with scholars based in United States, Germany and Australia. Sally A. Mullany's co-authors include Boris Winterhoff, William A. Cliby, Kathy R. Brandt, Sean C. Dowdy, Zenas Chang, Viji Shridhar, Jeremy Chien, Martina Bazzaro, Melissa A. Geller and Rahel Ghebre and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Cancer Research.

In The Last Decade

Sally A. Mullany

21 papers receiving 882 citations

Peers

Countries citing papers authored by Sally A. Mullany

Since Specialization

Citations

This map shows the geographic impact of Sally A. Mullany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally A. Mullany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally A. Mullany more than expected).

Fields of papers citing papers by Sally A. Mullany

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally A. Mullany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally A. Mullany. The network helps show where Sally A. Mullany may publish in the future.

Co-authorship network of co-authors of Sally A. Mullany

This figure shows the co-authorship network connecting the top 25 collaborators of Sally A. Mullany. A scholar is included among the top collaborators of Sally A. Mullany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally A. Mullany. Sally A. Mullany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining immune infiltrate heterogeneity by immunophenotyping of tumor micro-environment at single cell level: a step towards more effective personalized immunotherapy in ovarian cancer 2021 ·Gynecologic Oncology ·(unknown), (unknown), Jason Cepela, Mihir Shetty, Jinhua Wang, Andrew C. Nelson, Marissa Macchietto, Christine Henzler, Sally A. Mullany, Boris Winterhoff, Timothy K. Starr	1
2	Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery 2020 ·Gynecologic Oncology Reports ·Sally A. Mullany, David S. Miller, Katina Robison, (unknown), Yi-Chun Lee, S. Diane Yamada, Joan L. Walker, Maurie Markman, (unknown), (unknown), Gere S. diZerega	6
3	Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer 2019 ·International Journal of Molecular Sciences ·(unknown), Sally A. Mullany, Zenas Chang, Charles N. Landen, Stig Linder, Martina Bazzaro	87
4	Molecular characterization of endometrial cancer and therapeutic implications 2019 ·Current Opinion in Obstetrics & Gynecology ·Boris Winterhoff, Lauren Thomaier, Sally A. Mullany, Matthew A. Powell	41
5	Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions. 2018 ·eScholarship (California Digital Library) ·Boris Winterhoff, Stefan Kommoss, Florian Heitz, Gottfried E. Konecny, Sean C. Dowdy, Sally A. Mullany, (unknown), Klaus Baumann, Felix Hilpert, Sara Y. Brucker, Andreas du Bois, W. Schröder, Alexander Burges, Steven S. Shen, Jinhua Wang, (unknown), Sisi Ma, Jacobus Pfisterer, Constantin Aliferis	5
6	Molecular characterization of endometrial cancer and therapeutic implications 2018 ·Current Opinion in Obstetrics & Gynecology ·Zenas Chang, (unknown), Sally A. Mullany, Boris Winterhoff	37
7	Clinical utility of ubiquitin-specific protease 14 as a prognostic biomarker for endometrial cancer 2018 ·Gynecologic Oncology ·Minju Song, (unknown), Sarah Bedell, Tanya Pulver, (unknown), Rachel I. Vogel, Jenna Richter, Sally A. Mullany, Boris Winterhoff	1
8	Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells 2017 ·Gynecologic Oncology ·Boris Winterhoff, (unknown), Amit Mitra, Attila Sebe, Martina Bazzaro, Melissa A. Geller, Juan E. Abrahante, Molly Klein, (unknown), Sally A. Mullany, Kenneth B. Beckman, Jerry Daniel, Timothy K. Starr	77
9	Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service 2017 ·Obstetrics and Gynecology ·Elizabeth L. Dickson, (unknown), Melissa A. Geller, Rachel I. Vogel, Sally A. Mullany, Rahel Ghebre, (unknown), Levi S. Downs, Linda F. Carson, Deanna Teoh, (unknown), (unknown), Colleen Rivard, Britt Erickson, Jacob Hutchins, Peter A. Argenta	43
10	The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial 2016 ·Gynecologic Oncology ·Peter A. Argenta, Karla V. Ballman, Melissa A. Geller, Linda F. Carson, Rahel Ghebre, Sally A. Mullany, Deanna Teoh, Boris Winterhoff, Colleen Rivard, Britt Erickson	32
11	Molecular characterization of endometrial cancer and therapeutic implications 2016 ·Current Opinion in Obstetrics & Gynecology ·(unknown), Sally A. Mullany, Boris Winterhoff	14
12	Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed 2016 ·American Journal of Clinical Pathology ·(unknown), Sherine Salama, Rachel I. Vogel, Molly Klein, James M. Richter, Tanya Pulver, Sally A. Mullany, Boris Winterhoff	6
13	USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment 2016 ·Oncotarget ·Rachel I. Vogel, Tanya Pulver, (unknown), (unknown), Sally A. Mullany, Xianda Zhao, Maryam Shahi, (unknown), Molly Klein, Liqiang Chen, Rui Ding, Gottfried E. Konecny, Stefan Kommoss, Boris Winterhoff, Rahel Ghebre, Martina Bazzaro	39
14	Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective randomized controlled study 2015 ·Gynecologic Oncology ·Jacob Hutchins, Daniel J. Delaney, Rachel I. Vogel, Rahel Ghebre, Levi S. Downs, Linda F. Carson, Sally A. Mullany, Deanna Teoh, Melissa A. Geller	93
15	PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples 2015 ·European Journal of Cancer ·Boris Winterhoff, (unknown), Edward Hammond, Shailendra Giri, Susmita Mondal, Debarshi Roy, Attila Teoman, Sally A. Mullany, Robert Hoffmann, (unknown), Jeremy Chien, Matthew S. Block, Michael Millward, (unknown), Keith Dredge, Viji Shridhar	55
16	Early postoperative small bowel obstruction after laparoscopic myomectomy 2010 ·Fertility and Sterility ·(unknown), Sally A. Mullany, (unknown), T.M. Yalcinkaya	1
17	Expression and Functional Significance of HtrA1 Loss in Endometrial Cancer 2010 ·Clinical Cancer Research ·Sally A. Mullany, Mehdi Kebria, Ramandeep Rattan, Ashwani Khurana, Amy C. Clayton, Takayo Ota, Andrea Mariani, Karl C. Podratz, Jeremy Chien, Viji Shridhar	39
18	Loss of HSulf-1 Expression Enhances Autocrine Signaling Mediated by Amphiregulin in Breast Cancer 2007 ·Journal of Biological Chemistry ·Keishi Narita, Jeremy Chien, Sally A. Mullany, Julie Staub, Xiang Qian, Wilma L. Lingle, Viji Shridhar	66
19	The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma 2004 ·Cancer ·Sean C. Dowdy, Sally A. Mullany, Kathy R. Brandt, (unknown), William A. Cliby	143
20	Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity 1998 ·Cancer Chemotherapy and Pharmacology ·Sally A. Mullany, Phyllis A. Svingen, Scott H. Kaufmann, Charles Erlichman	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact